Summary We investigated the relation between benign ovarian tumours and lactose among 746 case women identified at seven New York metropolitan hospitals and 404 community controls, age and hospital frequency matched to the expected case distribution. No increase in risk was found for lactose (highest quartile versus lowest: adjusted odds ratio = 0.82 (95% CI 0.57-1.20) or for any other lactose foods.
Galactose levels are determined by dietary sources (primarily lactose) and metabolism-related factors. The theory linking galactose to ovarian cancer aetiology originates from galactosaemia, which is characterized by the absence of transferase. Some galactosaemics experience ovarian failure or have elevated gonadotropins levels (Kaufman et al, 1981) , which may increase ovarian cancer risk (Gardner, 1961; Cramer and Welch, 1983 ). An increased ovarian cancer risk has been reported with higher lactose intakes and with a higher lactose to transferase activity ratio (Cramer et al, 1989) .
The surgical diagnosis of benign epithelial tumours declines at ages when epithelial ovarian cancer incidence increases, suggesting that a small proportion of BOTs may progress to their invasive malignant counterparts (Bennington et al, 1968) . This is consistent with observations of benign neoplasia located adjacent to or within ovarian cancers (McKay, 1962; Puls et al, 1992) , and of benign to malignant epithelium histologic transition in onequarter of a sample of ovarian cancers (Puls et al, 1992) . Thus, benign and malignant ovarian tumours may share a common aetiology, and if so, they afford an opportunity to investigate potential risk factors closer to the time of aetiologic interest.
MATERIALS AND METHODS
Methods of this study have been described in more detail elsewhere . In this study English-speaking women, aged 18 to 74, with a telephone, residing in the New York metropolitan area within 50 miles of a participating hospital, having an ovary and not having a malignant tumour were eligible. Institutional review boards approved the study protocols.
BOT cases were diagnosed in 1992 and 1993. A uniform pathology review determined eligibility and histologic classification (Russell and Bannatyne, 1989) . Controls, frequency-matched to the expected case distribution by 10-year age group and hospital, were identified using Waksberg's random digit dialing (RDD) method (Waksberg, 1978; Hartge et al, 1984) . Participation rates among the cases and controls were 80.7% (n = 746) and 71.4% (n = 404), respectively. RDD screener response rate was 84.9%.
A structured questionnaire was administered. A 127-item Willett food frequency questionnaire (FFQ) (Willett, 1990) about usual dietary intake during the 12 to 24 months before interview was self-completed by 90% (n = 673) of the cases and 87% (n = 352) of the controls . Primary lactose foods included skim or low-fat milk, whole milk, cream, sour cream, sherbet or ice milk, ice cream, yogurt, cottage or ricotta cheese, cream cheese, and other cheeses such as American or cheddar cheese.
Median lactose intakes were compared by the Wilcoxon test (Conover, 1980) . Unconditional logistic regression produced adjusted odds ratios (ORs) and 95% confidence intervals (CIs) (Hosmer and Lemeshow, 1989) . Controls were compared to all cases and to the more common histologic sub-types: endometriomas, serious adenomas and teratomas.
Lactose (grams per day) was considered as a continuous and categorical variable (classified into quartiles). The residual nutrient method was used for the latter (Willett et al. 1997) . Foods were divided into three categories according to the control frequency distribution. In the models, categorical variables were represented as indicator variables and adjustment was made for age (<25/25-34/35-44/45-54/55-64/65+ years), hospital (seven categories), total energy (kilocalories per day), and body mass index (BMI: weight in kilograms/height in metres squared) for the year prior to interview. When dietary fat and non-dietary factors were considered as confounders, estimates were unaffected thus subsequent models omitted these factors. To assess trends, quartile levels or indicator variable scores were entered in models as ordinal variables.
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RESULTS
After exclusion of 1% of cases and controls with extreme energy intake (Howe et al, 1990; Hunter et al, 1996) 668 case women and 347 control women remained. Women could have multiple tumours of differing histology as a result the cases were diagnosed with 717 BOTs: 172 serous, 60 mucinous, 280 endometrioid, and 8 Brenner tumours, as well as 165 teratomas and 32 fibroma-thecomas. All women and those providing dietary information had similar distributions of demographic and other characteristics. In general, controls were significantly more likely than cases to be parous and to have a non-private or no health care provider, a possible indicator of less diagnosis opportunity. Cases were nonsignificantly more likely to be white, never OC users and have larger BMI. The mean case age of 42.2 years (standard deviation (SD) = 11.9) was slightly older than the mean control age of 41.5 years (SD = 12.5) (P = 0.4).
All cases combined and each histologic type, except endometriomas, had non-significantly higher median lactose intakes than controls (data not shown). There was no evidence of an association or a dose-response relation between lactose intake and BOTs or any of the histologic sub-types (Table 1) Only whole milk was associated with BOTs (Table 2) . A significant inverse relation was observed for all BOTs combined and for teratoma tumours, while a borderline significant inverse association was noted for tumours. Though these tests are indicative of an inverse trend, the observed association for the middle category of whole milk intake was either the same as or stronger than that observed for the highest category of intake. There were no other statistically significant associations or dose-response One woman with a teratoma and one with an endometrioma with missing information on body mass index (weight in kilograms/height in metres squared) were excluded from the logistic models.
c Adjusted for age, hospital, total caloric intake, and body mass index for the year prior to interview. One woman with a teratoma and one with an endometrioma with missing information on body mass index (weight in kilograms/height in metres squared) were excluded from the logistic models.
c Adjusted for age, hospital, total caloric intake, and body mass index for the year prior to interview. relations for BOTs combined or for the individual histologic subtypes and consumption of any other lactose foods (selected items shown in Table 2 ).
DISCUSSION
In this study, whole milk was the only item significantly associated with BOTs for which estimates were below the null. Adjustment for total and types of dietary fat as well as lactose did not change the association. Thus, our results do not support an increased BOT risk in relation to the lactose or dietary fat component of dairy products. This agrees with our earlier finding of no relation between BOTs and saturated fat .
If BOTs share a common aetiology with, or are precursors of malignant tumours, then the suggestion that either lactose or highfat dairy products (Mettlin and Piver, 1990) increase ovarian cancer risk is not supported by this study. Our null lactose findings are consistent with studies examining borderline (Risch et al, 1996) or malignant ovarian (Engle et al, 1991; Risch et al, 1994a; Herrinton et al, 1995; Mink et al, 1996; Webb et al, 1998) tumours, but contrast the findings of an elevated ovarian cancer risk in relation to lactose intake (Cramer et al, 1989) or in relation to the lactose to transferase ratio (Cramer et al, 1989) . Lactose consumption relative to metabolic capability may be a more relevant measure of galactose exposure but information on transferase activity or lactose tolerance was not available. Finally, we found a reduced BOT risk associated with higher whole milk consumption. Studies of ovarian cancer risk and either whole milk (Cramer et al, 1984 (Cramer et al, , 1989 Mettlin and Piver, 1990; Ursin et al, 1990; Risch et al, 1994a; Webb et al, 1998; Kushi et al, 1999) or dietary fat (Byers et al, 1983; Shu et al, 1989; Slattery et al, 1989; Tzonou et al, 1993; Rische et al, 1994b; Mink et al, 1996; Webb et al, 1998; Kushi et al, 1999) consumption have inconsistent findings, generally reporting no association or an elevated risk.
Participants in health-related studies might be more health conscious and therefore more likely to consume or report low-fat foods. This, coupled with the lower control response rate, could result in selection bias. Or, cases may be more motivated to provide truthful responses than controls, resulting in recall bias. These biases would result in an underestimation of low-fat, but an overestimation of high-fat, food associations. In light of the null findings, it is hard to conceive that these biases are selectively affecting low-fat food associations. Lactose findings should be unaffected because the lactose and fat content of foods are independent.
We assessed commonly eaten major and minor lactose sources enabling us to rank participants' lactose exposure. The foods assessed were similar to the short list of items examined in a study reporting a high correlation (r = 0.96) between lactose estimated using 34 versus 7 lactose foods (Cooper et al, 1995) . Among controls the expected ethnic/racial variation in lactose intake was observed (Scrimshaw and Murray, 1988) . These findings, together with the similar mean lactose intakes for our white controls and those in another study (Cramer et al, 1989) , lend credence to our lactose measure.
Overall the study's findings do not support an elevated BOT risk in relation to lactose and are consistent with the results of most of the ovarian cancer studies (Engle et al, 1991; Risch et al, 1994a Risch et al, , 1996 Herrinton et al, 1995; Mink et al, 1996; Webb et al, 1998) . The failure to detect an association might reflect a lack of power particularly in the histologic sub-type analyses. Finally, the reduction in BOT risk for greater whole milk intake could be a chance finding given the multiple comparisons made.
